Digital health startup Rimidi, formerly known as Rimidi Diabetes, has made its expanded mission official on the heels of a $6.575 million funding round. The capital came from new investors, pharmaceutical giant Eli Lilly and Company and Turner Investments, as well as existing investors Cox Enterprises, Village Capital, The